Genmab — Maj 2016
-
Bemærk kontrolarmen RevDex var med progression free survival på 18,4 måneder mod normalt 14 måneder for RevDex ekceptionel stærk.
-
Han løber fra mig i år Skygge.

-
Så kom der mail fra Genmab
-
He he

-
Læser du ikke til vores Q&A McJean.

-
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC478551/ Her lidt om HR
-
Ja hvis så Liverpool i aften taber til Sevilla, så bliver det da helt perfekt

Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind